Anti‐IL‐12/23p40 antibodies for maintenance of remission in Crohn's disease
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
The objectives of this review will be to assess the efficacy and safety of anti‐IL‐12/23p40 antibodies for maintenance of remission in Crohn's disease.